Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...

Anti-vaccine activists offered renowned CHOP immunologist and RFK target $1 million to debate them on vaccine safety ...

NewcelX Ltd. (Nasdaq: NCEL), a next-generation biotechnology company developing advanced cell-therapy and neuroscience-driven therapeutics, today announced the publication of a major international ...

Motorists suffering from particular sleep disorders must notify the Driver and Vehicle Licensing Agency (DVLA) or face potential fines reaching £1,000. Failure to inform authorities could also result ...

Takeda has said it intends to move quickly ahead with regulatory filings for oveporexton, its orexin agonist for sleep disorder narcolepsy, after a clean sweep of positive efficacy data in two phase 3 ...

Alkermes' alixorexton has become the first drug in the orexin 2 receptor agonist class to show efficacy in phase 2 trials involving patients with both main subtypes of sleep disorder narcolepsy.

We carry these mixed feelings into 2026, which is slated to be another great—yet perhaps troubled—year for science. No list ...

The etiology of the sleep disorder narcolepsy has not been firmly established, although an autoimmune pathogenesis has been proposed and is supported by a strong genetic association with the HLA. A ...

To add to this, this new game apparently has a "bold twist" which is part of a "vision that could only exist on Nintendo ...

With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about ...